Speciality Medicines IPO Subscription Status
Speciality Medicines IPO was subscribed 2.19 times when bidding closed on 24 Mar 2026: QIB 96.24x, NII 1.77x, Retail 0.85x.
The Speciality Medicines IPO has been subscribed 2.19x times overall. Retail investors have shown interest with bids for 0.85x the shares available. The Non-Institutional Investor (NII) category has been subscribed 1.77x. Qualified Institutional Buyers (QIBs) have subscribed 96.24x. Data last updated on 03 Sep, 02:08 PM.
The IPO subscription period has ended. The issue opened on 20 Mar, 2026 and closes on 24 Mar, 2026. The shares are expected to list on stock exchanges on 30 Mar, 2026.
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | 20,21,000 of 21,000 | 96.24x |
| NII | 21,94,000 of 12,39,000 | 1.77x |
| Retail | 9,22,000 of 10,90,000 | 0.85x |
| TOTAL | 51,37,000 | 2.19x |
Application-wise breakup (estimated)
Approximate application counts — the exchanges don't publish these during bidding. Estimated from shares bid using the typical application size seen in recent IPOs' Basis of Allotment data. Final counts appear here once the Basis of Allotment is out.
| Category | Est. Applied | Times | |
|---|---|---|---|
| Retail max 1,028 | 461 | 0.45x | |
| TOTAL (EST.) | 461 |
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Currently undersubscribed. Retail investors applying now have a high mathematical probability of receiving full allotment.
Institutional Backing
Massive institutional interest with QIBs subscribing 96.24x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
24 Mar 2026
Day 3 |
2.19x | ▼ | |
|
QIB96.24x
NII1.77x
Retail0.85x
|
|||
|
23 Mar 2026
Day 2 |
0.94x | ▼ | |
|
QIB1x
NII1.6x
Retail0.19x
|
|||
|
20 Mar 2026
Day 1 |
0.78x | ▼ | |
|
QIB1x
NII1.41x
Retail0.07x
|
|||
Speciality Medicines SME IPO dates
From the bidding window to listing. Today is 3 October.
- Open 20 Mar 2026
- Close 24 Mar 2026
- Allotment 25 Mar 2026
- Refund/credit 27 Mar 2026
- Listing 30 Mar 2026
Speciality Medicines IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds marked with applicant counts are computed from the exchange's actual application data (applicants ÷ allotment slots); others assume minimum-size bids at the current subscription multiple. Retail and HNI allotment is by SEBI-mandated lottery of the minimum application when oversubscribed; QIB allotment is proportionate. Numbers move until subscription closes. This is not investment advice.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Speciality Medicines IPO?
As of IPO close date (24 Mar, 2026), the Speciality Medicines IPO is subscribed 2.19x times. Retail category is 0.85x, and NII is 1.77x subscribed.
When is the allotment date for Speciality Medicines IPO?
The allotment for Speciality Medicines IPO is expected to be finalized on 25 March, 2026.
When will Speciality Medicines IPO list on the stock market?
Speciality Medicines is scheduled to list on BSE and NSE on 30 March, 2026.
What are the chances of getting allotment in Speciality Medicines IPO?
The retail category is currently undersubscribed at 0.85x, which means most applicants are likely to receive full allotment. This is a good window to apply if you haven't already.
What does QIB subscription of 96.24x mean for Speciality Medicines IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 96.24x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Speciality Medicines IPO allotment status?
After the allotment date (25 Mar, 2026), you can check your Speciality Medicines IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Speciality Medicines SME IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.